查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1797982

2032 年益智藥市場預測：按產品類型、形式、分銷管道、應用和地區進行的全球分析

Nootropics Market Forecasts to 2032 - Global Analysis By Product Type, Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球益智藥市場預計在 2025 年達到 57 億美元，到 2032 年將達到 157 億美元，預測期內的複合年成長率為 15.4%。

益智藥，又稱認知增強劑或智慧藥物，是旨在提高智力表現的天然或合成物質。這些化合物可以增強記憶力、注意力、創造力和警覺性等功能，且不會產生顯著的副作用。益智藥包括處方藥、膳食補充劑和咖啡因等興奮劑。其中一些已被臨床核准用於治療過動症和老年失智症疾病，而另一些則被列為仿單標示外，用於支持認知健康。

根據《食品科學與營養評論》發表的一篇系統性評價，分析了 2000 年至 2021 年間進行的 256 項人體研究，以評估植物來源益智藥的認知效果。

社會越來越重視心理健康和認知能力

隨著壓力、倦怠和數位疲勞達到歷史最高水平，消費者正在積極尋求能夠增強注意力、記憶力和情緒韌性的補充劑。這種需求涵蓋了廣泛的人群，從學生、專業人士到老年人，他們都認為改善認知功能對於提高生產力和生活品質至關重要。健康文化的興起，加上對健腦成分的科學檢驗日益增多，正在推動益智藥作為日常自我護理的一部分被主流接受。

缺乏統一的法律規範

益智藥通常處於膳食補充劑和藥物之間的灰色地帶，安全標準和標籤規範不一致。這種監管模糊性阻礙了產品核准，限制了國際貿易，並削弱了消費者信心。此外，在某些地區，未經證實的功效聲明和不合格配方的盛行可能會引發衛生部門的檢驗，並減緩知名品牌的創新和市場准入。

電子商務和線上零售的興起

線上平台為消費者提供豐富的產品選擇、個人化建議以及有助於長期認知提升的訂閱模式。網紅行銷、精準廣告和教育內容正在提昇科技使用者的認知度和試用率。此外，直銷品牌正在利用數據分析來改進配方，提高客戶維繫。這種向數位優先商務的轉變正在重塑分銷策略，並使利基新興企業能夠實現全球覆蓋。

負面宣傳與消費者的強烈反對

益智藥產業面臨聲譽風險，包括誇大宣傳、濫用和缺乏透明度。媒體對益智藥副作用和不道德銷售行為的報告可能會引發消費者的質疑和監管機構的打擊。此外，益智藥與績效壓力和學術興奮劑的關聯可能會疏遠注重健康的使用者。為了減輕負面影響，公司需要投資臨床研究、透明的標籤和負責任的通訊，強調安全性、有效性和全人益處。

COVID-19的影響：

新冠疫情對益智藥市場產生了雙重影響，既擾亂了供應鏈，也刺激了需求。封鎖和遠距辦公環境加劇了精神疲勞、焦慮和認知壓力，促使消費者尋求增強大腦功能的補充劑。天然適應原和情緒調節化合物因其緩解壓力的功效而廣受歡迎。在生產方面，採購和製造延遲導致暫時短缺，尤其是進口草藥成分的短缺。

天然益智藥市場預計將在預測期內佔據最大佔有率

由於消費者對潔淨標示植物性認知增強劑的偏好日益成長，因此預計天然益智藥領域將在預測期內佔據最大的市場佔有率。假馬齒莧、紅景天和猴頭菇等成分因其適應原和神經保護特性而備受青睞。這些化合物滿足了人們對永續、非合成健康解決方案日益成長的需求。萃取和生物利用度的技術進步正在提高功效，而阿育吠陀和中醫等傳統醫學體系的融合則正在拓展產品的多樣性。

預計在預測期內，記憶增強領域將以最高的複合年成長率成長。

受學術和專業表現日益成長的需求推動，記憶增強領域預計將在預測期內實現最高成長率。學生和職場人士正在轉向使用益智藥來增強回憶能力、提高學習速度和長期記憶。結合胞磷膽鹼、絲胺酸和草藥萃取物的配方因其協同效應而日益普及。此外，個人化組合和智慧交付系統的創新也使該領域受益，這些創新能夠最佳化認知結果。

佔比最大的地區：

預計北美將佔據最大的市場佔有率，在預測期內佔總收益的40%以上。該地區濃厚的健康文化、高可支配收入和先進的醫療基礎設施正在推動其普及。美國品牌在創新方面處於領先地位，提供素食、潔淨標示和整合技術的個人化產品，以滿足不同的認知需求。監管的明確性和消費者教育正在進一步推動市場成熟。

複合年成長率最高的地區：

預計北美將在預測期內實現最高的複合年成長率，這歸因於快速數位化和不斷變化的消費行為。電子商務、訂閱模式和網紅主導的宣傳活動的興起正在加速產品的普及。此外，該地區對預防性心理健康和個人化健康的關注正在推動配方和交付方面的創新。補充劑品牌與神經科學機構之間的策略合作夥伴關係進一步推動了成長，使北美成為認知增強技術的全球中心。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球益智藥市場（依產品類型）

  • 天然益智藥
    • 草本萃取物
    • 胺基酸
    • Omega-3脂肪酸
  • 合成益智藥
    • 拉西坦
    • 安帕基尼斯
    • 膽鹼能促效劑
  • 處方箋藥
    • Modafinil
    • 阿屈非尼
  • 其他產品類型

6. 全球益智藥市場（依形式）

  • 膠囊/片劑
  • 粉末
  • 喝
  • 其他形式

7. 全球益智藥市場（按分銷管道）

  • 線上管道
  • 線下通路
    • 藥局和藥局
    • 超級市場和大賣場
    • 專賣店

8. 全球益智藥市場（按應用）

  • 提升記憶力
  • 提高專注力和專注力
  • 情緒和壓力管理
  • 抗衰老和神經保護
  • 疾病或受傷後的認知恢復
  • 其他用途

9. 全球益智藥市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要發展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Purelife Bioscience Co., Ltd.
  • TruBrain
  • HVMN Inc.
  • Peak Nootropics
  • SupNootropic Bio Co. Ltd.
  • AlternaScript HQ
  • Onnit Labs LLC
  • Accelerated Intelligence, Inc.
  • Merck & Co.
  • OptiMind
  • Clarity Nootropics
  • F. Hoffmann-La Roche Ltd.
  • Neurohacker Collective
  • AstraZeneca
  • Janssen Pharmaceuticals
  • Gaia Herbs, Inc.
  • Mind Lab Pro
Product Code: SMRC30352

According to Stratistics MRC, the Global Nootropics Market is accounted for $5.7 billion in 2025 and is expected to reach $15.7 billion by 2032 growing at a CAGR of 15.4% during the forecast period. Nootropics, is a cognitive enhancers or smart drugs, are natural or synthetic substances that aim to improve mental performance. These compounds may enhance functions such as memory, attention, creativity, and alertness without causing significant side effects. Nootropics include prescription medications, dietary supplements, and stimulants like caffeine. While some are clinically approved for conditions like ADHD or Alzheimer's, others are used off-label to support cognitive health, though scientific evidence for their effectiveness in healthy individuals remains limited

According to a systematic review published in Critical Reviews in Food Science and Nutrition, 256 human studies conducted between 2000 and 2021 were analyzed to assess the cognitive effects of plant-derived nootropics.

Market Dynamics:

Driver:

Increasing societal emphasis on mental well-being, cognitive performance

As stress, burnout, and digital fatigue become widespread, consumers are actively seeking supplements that enhance focus, memory, and emotional resilience. This demand spans across demographics from students and professionals to aging populations who view cognitive enhancement as essential to productivity and quality of life. The rise of wellness culture, coupled with increased scientific validation of brain-boosting ingredients, is fostering mainstream acceptance of nootropics as part of daily self-care routines.

Restraint:

Lack of uniform regulatory oversight

Nootropics often fall into a gray area between dietary supplements and pharmaceuticals, leading to inconsistent safety standards and labeling practices. This regulatory ambiguity can hinder product approvals, limit international trade, and erode consumer trust. Moreover, the proliferation of unverified claims and substandard formulations in some regions has prompted scrutiny from health authorities, potentially slowing innovation and market entry for reputable brands.

Opportunity:

Expansion of E-commerce and online retail

Online platforms offer consumers access to a wide array of products, personalized recommendations, and subscription-based models that support long-term cognitive enhancement. Influencer marketing, targeted ads, and educational content are driving awareness and trial among tech-savvy users. Additionally, direct-to-consumer brands are leveraging data analytics to refine formulations and improve customer retention. This shift toward digital-first commerce is reshaping distribution strategies and enabling global reach for niche and emerging players.

Threat:

Negative publicity and consumer backlash

The nootropics industry faces reputational risks stemming from exaggerated claims, misuse, and lack of transparency. Media coverage of adverse effects or unethical marketing practices can trigger consumer skepticism and regulatory crackdowns. Furthermore, the association of nootropics with performance pressure or academic doping may alienate wellness-focused users. To mitigate backlash, companies must invest in clinical research, transparent labeling, and responsible messaging that emphasizes safety, efficacy, and holistic benefits.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the nootropics market, disrupting supply chains while simultaneously amplifying demand. Lockdowns and remote work environments intensified mental fatigue, anxiety, and cognitive strain, prompting consumers to explore brain-enhancing supplements. Natural adaptogens and mood-regulating compounds gained popularity for their stress-relief properties. On the production side, delays in sourcing and manufacturing led to temporary shortages, especially for imported herbal ingredients.

The natural nootropics segment is expected to be the largest during the forecast period

The natural nootropics segment is expected to account for the largest market share during the forecast period driven by rising consumer preference for clean-label, plant-based cognitive enhancers. Ingredients such as Bacopa monnieri, Rhodiola rosea, and Lion's Mane mushroom are favored for their adaptogenic and neuroprotective properties. These compounds align with the growing demand for sustainable, non-synthetic wellness solutions. Technological advancements in extraction and bioavailability are improving efficacy, while the integration of traditional medicine systems like Ayurveda and TCM is expanding product diversity.

The memory enhancement segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the memory enhancement segment is predicted to witness the highest growth rate fueled by increasing academic and professional performance demands. Students and working professionals are turning to nootropics that support recall, learning speed, and long-term retention. Formulations combining citicoline, phosphatidylserine, and herbal extracts are gaining popularity for their synergistic effects. The segment is also benefiting from innovations in personalized stacks and smart delivery systems that optimize cognitive outcomes.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share accounting for over 40% of total revenue. The region's strong wellness culture, high disposable income, and advanced healthcare infrastructure support widespread adoption. U.S.-based brands lead in innovation, offering vegan, clean-label, and tech-integrated products tailored to diverse cognitive needs. Regulatory clarity and consumer education further enhance market maturity.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to rapid digital adoption and evolving consumer behavior. The proliferation of e-commerce, subscription models, and influencer-led campaigns is accelerating product uptake. Moreover, the region's emphasis on preventive mental health and personalized wellness is fostering innovation in formulation and delivery. Strategic partnerships between supplement brands and neuroscience labs are further propelling growth, positioning North America as a global hub for cognitive enhancement technologies

Key players in the market

Some of the key players in Nootropics Market include Purelife Bioscience Co., Ltd., TruBrain, HVMN Inc., Peak Nootropics, SupNootropic Bio Co. Ltd., AlternaScript HQ, Onnit Labs LLC, Accelerated Intelligence, Inc., Merck & Co., OptiMind, Clarity Nootropics, F. Hoffmann-La Roche Ltd., Neurohacker Collective, AstraZeneca, Janssen Pharmaceuticals, Gaia Herbs, Inc. and Mind Lab Pro.

Key Developments:

In June 2025, Accelerated Intelligence, Inc. Company launched new digital content and coaching tools focused on emotional intelligence and cognitive performance. Excelerol remains its flagship supplement.

In June 2025, AstraZeneca announced a major expansion of its Global Hub in Bangalore, adding 400 jobs and boosting AI-driven R&D. The move supports its goal of delivering 20 new medicines by 2030.

In March 2025, OptiMind entered a letter of intent to acquire Monjin, an AI-powered recruitment platform. The deal includes equity restructuring and a name change to reflect expanded business focus.

Product Types Covered:

  • Natural Nootropics
  • Synthetic Nootropics
  • Prescription Nootropics
  • Other Product Types

Forms Covered:

  • Capsules/Tablets
  • Powders
  • Drinks/Beverages
  • Other Forms

Distribution Channels Covered:

  • Online Channels
  • Offline Channels

Applications Covered:

  • Memory Enhancement
  • Attention & Focus Improvement
  • Mood & Stress Management
  • Anti-Aging & Neuroprotection
  • Cognitive Recovery after Illness or Injury
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nootropics Market, By Product Type

  • 5.1 Introduction
  • 5.2 Natural Nootropics
    • 5.2.1 Herbal Extracts
    • 5.2.2 Amino Acids
    • 5.2.3 Omega-3 Fatty Acids
  • 5.3 Synthetic Nootropics
    • 5.3.1 Racetams
    • 5.3.2 Ampakines
    • 5.3.3 Cholinergics
  • 5.4 Prescription Nootropics
    • 5.4.1 Modafinil
    • 5.4.2 Adrafinil
  • 5.5 Other Product Types

6 Global Nootropics Market, By Form

  • 6.1 Introduction
  • 6.2 Capsules/Tablets
  • 6.3 Powders
  • 6.4 Drinks/Beverages
  • 6.5 Other Forms

7 Global Nootropics Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Channels
  • 7.3 Offline Channels
    • 7.3.1 Pharmacies & Drugstores
    • 7.3.2 Supermarkets & Hypermarkets
    • 7.3.3 Specialty Stores

8 Global Nootropics Market, By Application

  • 8.1 Introduction
  • 8.2 Memory Enhancement
  • 8.3 Attention & Focus Improvement
  • 8.4 Mood & Stress Management
  • 8.5 Anti-Aging & Neuroprotection
  • 8.6 Cognitive Recovery after Illness or Injury
  • 8.7 Other Applications

9 Global Nootropics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Purelife Bioscience Co., Ltd.
  • 11.2 TruBrain
  • 11.3 HVMN Inc.
  • 11.4 Peak Nootropics
  • 11.5 SupNootropic Bio Co. Ltd.
  • 11.6 AlternaScript HQ
  • 11.7 Onnit Labs LLC
  • 11.8 Accelerated Intelligence, Inc.
  • 11.9 Merck & Co.
  • 11.10 OptiMind
  • 11.11 Clarity Nootropics
  • 11.12 F. Hoffmann-La Roche Ltd.
  • 11.13 Neurohacker Collective
  • 11.14 AstraZeneca
  • 11.15 Janssen Pharmaceuticals
  • 11.16 Gaia Herbs, Inc.
  • 11.17 Mind Lab Pro

List of Tables

  • Table 1 Global Nootropics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Nootropics Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Nootropics Market Outlook, By Natural Nootropics (2024-2032) ($MN)
  • Table 4 Global Nootropics Market Outlook, By Herbal Extracts (2024-2032) ($MN)
  • Table 5 Global Nootropics Market Outlook, By Amino Acids (2024-2032) ($MN)
  • Table 6 Global Nootropics Market Outlook, By Omega-3 Fatty Acids (2024-2032) ($MN)
  • Table 7 Global Nootropics Market Outlook, By Synthetic Nootropics (2024-2032) ($MN)
  • Table 8 Global Nootropics Market Outlook, By Racetams (2024-2032) ($MN)
  • Table 9 Global Nootropics Market Outlook, By Ampakines (2024-2032) ($MN)
  • Table 10 Global Nootropics Market Outlook, By Cholinergics (2024-2032) ($MN)
  • Table 11 Global Nootropics Market Outlook, By Prescription Nootropics (2024-2032) ($MN)
  • Table 12 Global Nootropics Market Outlook, By Modafinil (2024-2032) ($MN)
  • Table 13 Global Nootropics Market Outlook, By Adrafinil (2024-2032) ($MN)
  • Table 14 Global Nootropics Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 15 Global Nootropics Market Outlook, By Form (2024-2032) ($MN)
  • Table 16 Global Nootropics Market Outlook, By Capsules/Tablets (2024-2032) ($MN)
  • Table 17 Global Nootropics Market Outlook, By Powders (2024-2032) ($MN)
  • Table 18 Global Nootropics Market Outlook, By Drinks/Beverages (2024-2032) ($MN)
  • Table 19 Global Nootropics Market Outlook, By Other Forms (2024-2032) ($MN)
  • Table 20 Global Nootropics Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 21 Global Nootropics Market Outlook, By Online Channels (2024-2032) ($MN)
  • Table 22 Global Nootropics Market Outlook, By Offline Channels (2024-2032) ($MN)
  • Table 23 Global Nootropics Market Outlook, By Pharmacies & Drugstores (2024-2032) ($MN)
  • Table 24 Global Nootropics Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 25 Global Nootropics Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 26 Global Nootropics Market Outlook, By Application (2024-2032) ($MN)
  • Table 27 Global Nootropics Market Outlook, By Memory Enhancement (2024-2032) ($MN)
  • Table 28 Global Nootropics Market Outlook, By Attention & Focus Improvement (2024-2032) ($MN)
  • Table 29 Global Nootropics Market Outlook, By Mood & Stress Management (2024-2032) ($MN)
  • Table 30 Global Nootropics Market Outlook, By Anti-Aging & Neuroprotection (2024-2032) ($MN)
  • Table 31 Global Nootropics Market Outlook, By Cognitive Recovery after Illness or Injury (2024-2032) ($MN)
  • Table 32 Global Nootropics Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.